newsfilter
← Latest News
Business Wire·

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

OpRegen® Granted Regenerative Medicine Advanced Therapy (RMAT) Designation From FDA ReSonance™ (ANP1) Preclinical Results Presented at 59th Annual Inner Ear Biology Workshop Added to 2024 Russell